kund
7 minutes ago
Leqembi’s MAA was filed in January 2023, and the first decision came in July 2024—an 18-month process. Eisai and Biogen are major players who can respond to EMA queries much faster than Anavex. Similarly, donanemab’s MAA was filed in July 2023, and there’s still no decision to date. EMA is a bureauc